Status:
RECRUITING
Prevention of Post-sphincterotomy Bleeding
Lead Sponsor:
National Cheng-Kung University Hospital
Conditions:
Post-ERCP Bleeding
Eligibility:
All Genders
18-95 years
Phase:
NA
Brief Summary
Background and Aim: Endoscopic retrograde cholangiopancreatography (ERCP) and sphincterotomy (EST) are standard treatments for choledocholithiasis. However, 10% of post-EST bleeding was reported. Curr...
Detailed Description
Endoscopic retrograde cholangiopancreatography (ERCP) is an advanced endoscopic procedure combining endoscopy and fluoroscopy to diagnose and treat diseases of the pancreaticobiliary ductal system, in...
Eligibility Criteria
Inclusion
- Patients aged ≥ 18 years who accept ERCP and sphincterotomy for common bile duct (CBD) stone extraction
Exclusion
- Paitnets with no schedules for sphincterotomy
- Paitnets with unsuccessful CBD cannulation
- Patients with allergy to sucralfate
Key Trial Info
Start Date :
January 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 31 2025
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT06107504
Start Date
January 1 2024
End Date
July 31 2025
Last Update
May 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cheng-Kung University Hospital
Tainan, Other (Non U.s.), Taiwan, 704